Hippo Holdings Inc. Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Numerator: | |||||||||||||||||
Net loss attributable to Hippo – basic and diluted (in millions) | $ | (40.5) | $ | (273.1) | $ | (333.4) | |||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average shares used in computing net loss per share attributable to Hippo — basic and diluted | 24,699,913 | 23,578,922 | 22,747,101 | ||||||||||||||
| Net loss per share attributable to Hippo — basic and diluted | $ | (1.64) | $ | (11.58) | $ | (14.66) | |||||||||||
| December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Outstanding options | 1,152,878 | 1,589,529 | 1,986,978 | ||||||||||||||
| Warrants to purchase common shares | 360,000 | 360,000 | 360,000 | ||||||||||||||
| Common stock subject to repurchase | — | 26,058 | 76,364 | ||||||||||||||
| RSU and PRSUs | 1,738,781 | 2,534,683 | 2,881,984 | ||||||||||||||
| Total | 3,251,659 | 4,510,270 | 5,305,326 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Mar 6, 2025 | Showing above |
| 2022 | Mar 2, 2023 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.